Needham & Company
-
Intermolecular's (IMI) Technology Warrant's Premium, Says Analyst
-
Needham & Company Maintains a 'Buy' on Intermolecular (IMI); Strong Q1 on Continued Relationship Building
-
Needham & Company Reiterates a 'Buy' on Intermolecular (IMI); 4Q11 Results and Expansion of Guardian Contract Highlight Progress
-
Needham & Company Starts Intermolecular (IMI) at Buy; A Trail Blazer in Semiconductor Process Technology
-
Intermolecular (IMI) Files $200M IPO

